Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C
✍ Scribed by Peter Derek Christian Leutscher; Martin Lagging; Mads Rauning Buhl; Court Pedersen; Gunnar Norkrans; Nina Langeland; Kristine Mørch; Martti Färkkilä; Simon Hjerrild; Kristoffer Hellstrand; Per Bech; for the NORDynamIC Group
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 202 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Cannabinoids present in Cannabis sativa (marijuana) exert biological effects via cannabinoid receptors CB1 and CB2. We recently demonstrated that CB1 and CB2 receptors regulate progression of experimental liver fibrosis. We therefore investigated the impact of cannabis smoking on fibrosis progressio
To elucidate the risk factors for liver carcinogenesis and to examine the incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients treated with interferon were followed by ultrasonography for 13 to 97 months (median 36 months). Sustained response with
## Abstract ## BACKGROUND Hepatic steatosis is one of the histopathologic features of chronic hepatitis C. It was reported recently that the expression of hepatitis C virus (HCV) core protein in transgenic mice induced hepatocellular carcinoma (HCC) in association with steatosis. The objective of
## Abstract Hepatitis C virus (HCV), the major causative agent of non‐A, non‐B hepatitis, is transmitted by parenteral exposure. Transmission by sexual activity, however, is controversial. Possible behavioral risk factors for HCV infection were studied retrospectively among imprisoned men (n = 201,